Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Kansas selects NPLEx to track PSE purchases

This article was originally published in The Tan Sheet

Executive Summary

Kansas becomes the fifth state to take up the Consumer Healthcare Products Association's offer to monitor methamphetamine precursor purchases at no cost to the state. Missouri, Illinois, Kentucky and Louisiana have already said they will implement the industry-funded National Precursor Log Exchange to help enforce purchase limits for pseudoephedrine-containing OTCs. CHPA announced the Kansas Board of Pharmacy's decision March 22. While Mississippi recently became the second state to make all PSE drugs available Rx only, CHPA hopes other states will elect to use the tracking system (1"The Tan Sheet" Feb. 8, 2010)

You may also be interested in...



Louisiana kicks off PSE e-tracking

Louisiana implements the National Precursor Log Exchange June 15 to monitor purchases of OTC products containing pseudoephedrine. Industry bears the cost of deploying and supporting NPLEx through the Consumer Healthcare Products Association, which advocates for electronic tracking of methamphetamine precursors over prescription-only status (1"The Tan Sheet" March 29, 2010, In Brief). Louisiana Gov. Bobby Jindal called NPLEx "a critical tool to help crack down on the sale of drugs that are used to produce meth." Kentucky and Illinois also fully implemented NPLEx. Alabama, Florida, Iowa, Kansas, Missouri, South Carolina and Washington State passed legislation to adopt the NPLEx system, but have yet to implement it, according to CHPA. Oklahoma and Arkansas use separate e-tracking systems. Oregon and Mississippi shifted PSE products to Rx-only availability

Mississippi PSE Prescription Switch Will Not Start An Avalanche - CHPA

Mississippi lawmakers' decision to make all pseudoephedrine-containing drugs prescription-only will not prompt other states combating methamphetamine to do the same, the Consumer Healthcare Products Association predicts

2022 Korean VC Financings Led By Mid-Stage Bioventures

Amid a generally harsh environment, venture capital investors in South Korea appeared to take a more selective approach in 2022, with more established and financially stable domestic bioventures the biggest beneficiaries.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS103945

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel